Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of substance inhibiting angiopoietin-like protein 8

An angiogenin and protein technology, applied in the field of biomedicine, can solve the problems of poor control of hypertension and increased incidence of vascular remodeling, and achieve the effects of reducing thickness, slowing collagen deposition, and inhibiting stress pathways

Pending Publication Date: 2020-01-17
BEIJING ANZHEN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there are a variety of drugs to lower blood pressure clinically, such as angiotensin II inhibitors, angiotensin II receptor antagonists, calcium ion channel inhibitors, diuretics, etc.; however, the control rate of hypertension is still poor, and hypertension And the incidence of vascular remodeling caused by it is increasing year by year

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of substance inhibiting angiopoietin-like protein 8
  • Application of substance inhibiting angiopoietin-like protein 8
  • Application of substance inhibiting angiopoietin-like protein 8

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029] The specific implementation manner of the present application will be described below in conjunction with the accompanying drawings.

[0030] In the present invention, unless otherwise specified, the scientific and technical terms used herein have the meanings commonly understood by those skilled in the art. Moreover, the reagents, materials and operation steps used herein are all reagents, materials and routine procedures widely used in the corresponding fields. Meanwhile, in order to better understand the present invention, definitions and explanations of related terms are provided below.

[0031] Angiopoietin-like protein (ANGPTL) is a family of secreted protein factors not only related to angiogenesis, but also closely related to lipid metabolism, glucose metabolism, energy metabolism and insulin sensitivity. The ANGPTLs family contains 8 members and is a class of secreted proteins. Except Angiopoietin-like protein 5 (ANGPTL5) which is only expressed in human body...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of a substance inhibiting angiopoietin-like protein 8. The application includes application of the substance inhibiting the angiopoietin-like protein 8 in preparation of products for preventing or treating diseases related to hypertension and / or vascular remodeling. The application of the substance inhibiting the angiopoietin-like protein 8 has the advantages that the substance inhibiting the angiopoietin-like protein 8 inhibits endoplasmic reticulum stress pathways of smooth muscle cells and suppresses proliferation and migration of the smooth muscle cells by inhibiting collagen deposition, and further can effectively reduce the blood pressure and the thickness of blood vessel walls, so that hypertension and vascular remodeling are prevented and treatedeffectively; the substance inhibiting the angiopoietin-like protein 8 can effectively improve the therapeutic effect on hypertension and vascular remodeling when being applied to the products for preventing or treating the diseases related to the hypertension and / or vascular remodeling, thereby having a good application prospect.

Description

technical field [0001] This application relates to the field of biomedical technology, in particular to the application of a substance that inhibits angiopoietin-like protein 8. Background technique [0002] Hypertension (hypertension) refers to an increase in systemic arterial blood pressure (systolic and / or diastolic) as the main feature (systolic blood pressure ≥ 140 mm Hg, diastolic blood pressure ≥ 90 mm Hg), which may be accompanied by heart, brain, kidney, etc. Clinical syndrome of functional or organic damage to organs. [0003] The dilation and contraction of blood vessels, the distribution of blood flow in the lumen and the flow speed of blood in the lumen will change at any time with the body's metabolism and needs. Compared with this significant change in hemodynamics, the structure of the blood vessel wall is relatively stable within a certain range; however, with the development of blood vessel growth and aging process, some obvious changes will occur in its s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61P9/12A61P9/00
CPCA61K45/00A61P9/12A61P9/00
Inventor 秦彦文焦晓璐
Owner BEIJING ANZHEN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products